Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroprevalence of Antibodies to Measles, Mumps, and Rubella, and Serologic Responses After Vaccination Among Human Immunodeficiency Virus (HIV)-1 Infected Adults in Northern Thailand

NCT02724852 is registered in ClinicalTrials.gov with Chiang Mai University as lead sponsor.

NCT NCT02724852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02724852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroprevalence of Antibodies to Measles, Mumps, and Rubella, and Serologic Responses After Vaccination Among Human Immunodeficiency Virus (HIV)-1 Infected Adults in Northern Thailand
Lead sponsor
Chiang Mai University
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2011
Completion date
March 31, 2014
Enrollment
632 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv